---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-23-000071"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2023-10-02T23:59:59+00:00"
generated_at: "2026-06-10T06:22:27.876350+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Avanos closes sale of Respiratory Health business to SunMed for $110M cash

## Summary
- Divestiture of Avanos' Respiratory Health business closed Oct 2, 2023; $110M cash purchase price subject to adjustments for indebtedness, inventory, and chargebacks.
- Amendment adds Assumed Chargeback Liabilities definition; purchase price reduced by estimated chargeback amount with final adjustment by Oct 31, 2023.
- India-related assets transferred separately at $910,000 purchase price; India purchase agreement to be executed post-closing.
- Indemnification cap for India VAT losses set at $172,000; other amendments modify purchase price calculation and escrow details.

## SEC filing metadata
- accession: 0001606498-23-000071
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2023-10-02T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000071/0001606498-23-000071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000071/avns-20231002.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-23-000071
- JSON: https://secwatch.observer/filing/0001606498-23-000071.json
- Plain text: https://secwatch.observer/filing/0001606498-23-000071.txt

## Key facts
- M&A Transactions
  AVANOS MEDICAL, INC. completed a disposition involving SunMed Group Holdings, LLC for $110 million in cash (closed 2023-10-02).
  - Action: disposition
  - Counterparty: SunMed Group Holdings, LLC
  - Consideration: $110 million in cash
  - Closing: 2023-10-02
  source text: Health (“RH”) business (the “Divestiture”). In accordance with the Amended Purchase Agreement, the total purchase price paid by Buyer in connection with the Divestiture was $110 million in cash at the closing, subject to certain adjustments as provided in the Amended Purchase Agreement based on the indebtedness and inventory transferred to Buyer at the closing
  evidence_url: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000071/0001606498-23-000071-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.